Clinical Medication Guidelines for Glaucoma

Title: Clinical Medication Guidelines for Glaucoma
Edition: Original
Classification: Standard guideline
Field: Treatment
Countries and regions: China
Guidelines users: Ophthalmologist, pharmacist and nurse
Evidence classification method:
Development unit: the Chinese Pharmaceutical Association, Hospital Pharmacy Professional Committee; the Chinese Pharmaceutical Association, Evidence-based Pharmacy Professional Committee; Peking University Third Hospital; Institute for drug evaluation, Peking University Health Science Center
Registration time: 2021-01-15
Registration number: IPGRP-2021CN009
Purpose of the guideline: Based on the method of evidence-based pharmacy, this guideline aims to integrate the resources and strength of ophthalmology pharmacy, summarize the best evidence available for clinical medication of glaucoma patients, and provide appropriate recommendations for clinical medication of glaucoma patients combined with physicians' experience and patients' preference.